Georgia House Passes Bill to Expand Medical Cannabis Program
Georgia medical cannabis expansion will increase patient eligibility and require clinicians to update screening and dosing protocols. The new bill reflects evidence-based policy development. Providers should prepare for changes in clinical practice and…
420 with CNW — Study Suggests Marijuana Compounds Could Potentially Reverse Liver Disorder
Recent research on cannabinoid compounds liver disorder shows promising therapeutic potential in reversing liver dysfunction. These findings add to the growing evidence supporting cannabis-based treatments for hepatic diseases. However, further clinical…
Quasi-randomization to Cannabinoid Condition in Studies of US Legal Market Cannabis
Quasi-randomization cannabis studies face unique challenges due to federal Schedule I restrictions that limit true randomization. These studies often involve selection bias, affecting the reliability of cannabis clinical evidence. Understanding these…
Medicinal Cannabis Eases Endometriosis and Pelvic Pain
Medicinal cannabis endometriosis pain relief is gaining attention for its potential to ease pelvic pain symptoms. Emerging evidence suggests cannabinoids may modulate inflammatory and neurobiological pathways involved in endometriosis. However, clinical…
New Research Suggests Cannabis May Improve Women’s Sexual Health
Emerging research highlights cannabis sexual health benefits for women, suggesting potential improvements in sexual function and intimacy. Clinicians should be aware of these findings to provide informed counseling. Understanding cannabis's role in…
Marijuana – Point of View
Cannabis safety research is essential for clinicians to provide informed counseling about cannabis risks. Emerging evidence highlights the importance of understanding adverse effects. This research supports balanced clinical guidance on cannabis use.
The Impact of Rescheduling Cannabis on Federal Research Changes
Rescheduling cannabis research federal changes remove significant barriers to clinical trials. This shift enables physicians to rely on evidence-based data for prescribing decisions. It marks a critical move toward advancing patient care and expanding…
CBD and CBG: Promising Treatments for Fatty Liver Disease
A new CBD and CBG fatty liver disease study highlights promising therapeutic potential for metabolic liver conditions. These cannabinoids may reduce liver fat and improve metabolic health. This study offers hope for new treatment options beyond lifestyle…
Study Suggests CBD and CBG Could Be Treatment for Chronic Liver Disease
Recent research highlights the cannabigerol therapeutic potential review for chronic liver disease. CBD and CBG show promise in addressing fatty liver disease. These findings may expand treatment options for millions affected.
Federal Marijuana Rescheduling May Speed Tennessee MMJ Legalization
Federal marijuana rescheduling Tennessee medical cannabis could remove barriers to clinical research and accelerate legalization in Tennessee. This shift allows clinicians to access evidence-based data for patient care. It also enables a legal framework…
